Home / Inspections / 1219358

FDA Inspection 1219358 — Neos Therapeutics, LP

Neos Therapeutics, LP — FEI 3000205839

The FDA completed an inspection of Neos Therapeutics, LP on August 25, 2023 in Grand Prairie, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 25, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Grand Prairie, TX (United States)

Facility

Other inspections at this facility

  • 1067923 (NAI Fri Sep 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1021339 (VAI Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 929403 (VAI Thu Jun 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 730235 (VAI Fri May 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 648165 (VAI Fri Feb 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources